{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:44:14Z","timestamp":1752983054255,"version":"3.40.5"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,23]]},"abstract":"<jats:p>Colon cancer is a common digestive tract tumor. Although many gene prognostic indicators have been used to predict the prognosis of colon cancer patients, the accuracy of these prognostic indicators is still uncertain. Thus, it is necessary to construct a model for the prognostic analysis of colon cancer. We downloaded the original transcriptome data of colon cancer and performed a differential coexpression analysis of immune-related genes to obtain different immune-related long noncoding RNAs, which were paired as differentially expressed immune-related lncRNA pairs (DEirlncRNAPs). Then, the 1-year overall survival rate receiver operating characteristic curve was calculated, and the Akaike information criterion value was evaluated to determine the maximum inflection point, which was used as the cutoff point to identify groups of colon cancer patients at high and low risk for death. Subsequently, the optimal prediction model was established. Finally, we used the patients\u2019 survival times, clinicopathological features, tumor infiltrating immune cells, chemotherapy responses, and immunosuppressive biomarkers to verify the DEirlncRNAP model. Seventy-one DEirlncRNAPs were obtained to build the risk assessment model. The patients were divided into a high-risk group and a low-risk group according to the cutoff point. Then, the DEirlncRNAP model was verified using patient survival times, clinicopathological features, tumor-infiltrating immune cells, chemotherapy responses, and immunosuppressive biomarkers. A new DEirlncRNAP model for predicting the prognosis of colon cancer patients was established, which could reveal new insights into the relationships of colon cancer with tumor-infiltrating immune cells and antitumor immunotherapy.<\/jats:p>","DOI":"10.1097\/md.0000000000030447","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:23:44Z","timestamp":1663943024000},"page":"e30447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Constructing a prognostic immune-related lncRNA model for colon cancer"],"prefix":"10.1097","volume":"101","author":[{"given":"Xinyun","family":"Li","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Sichuan College of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Sichuan College of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangshu","family":"Rao","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-6214","authenticated-orcid":false,"given":"Yu","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.coi.2013.03.004","article-title":"From the immune contexture to the immunoscore: the role of prognostic and predictive immune markers in cancer.","volume":"25","author":"Angell","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers.","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.","volume":"27","author":"Salama","year":"2009","journal-title":"J Clin Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1634\/theoncologist.2019-0129","article-title":"Safety of nivolumab plus low-dose ipilimumab in previously treated microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer.","volume":"24","author":"Morse","year":"2019","journal-title":"Oncologist"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.oraloncology.2011.07.008","article-title":"Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions.","volume":"47","author":"Gibb","year":"2011","journal-title":"Oral Oncol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/carcin\/bgp181","article-title":"Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.","volume":"31","author":"Tsang","year":"2010","journal-title":"Carcinogenesis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/gb-2012-13-8-r75","article-title":"Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.","volume":"13","author":"Brunner","year":"2012","journal-title":"Genome Biol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fgene.2020.00318","article-title":"Identification of an immune-related nine-lncRNA signature predictive of overall survival in colon cancer.","volume":"11","author":"Lin","year":"2020","journal-title":"Front Genet"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.omtn.2020.10.002","article-title":"Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma.","volume":"22","author":"Hong","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT.","volume":"1711","author":"Chen","year":"2018","journal-title":"Cancer Syst Biol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e1142","DOI":"10.1002\/cti2.1142","article-title":"Immune microenvironment composition in non-small cell lung cancer and its association with survival.","volume":"9","author":"Tamminga","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","article-title":"Cell-type enrichment analysis of bulk transcriptomes using xCell.","volume":"2120","author":"Dvir","year":"2020","journal-title":"Methods Mol Biol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00262-017-2058-z","article-title":"Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies.","volume":"67","author":"Petitprez","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.","volume":"6","author":"Racle","year":"2017","journal-title":"eLife"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells.","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.seminoncol.2011.05.004","article-title":"Perspectives on current Tumor-Node-Metastasis (TNM) staging of cancers of the colon and rectum.","volume":"38","author":"Hu","year":"2011","journal-title":"Semin Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e12829","DOI":"10.1111\/sji.12829","article-title":"Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: a meta-analysis.","volume":"91","author":"Liu","year":"2020","journal-title":"Scand J Immunol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1200\/JCO.2005.05.0229","article-title":"Stage II colon cancer prognosis prediction by tumor gene expression profiling.","volume":"24","author":"Barrier","year":"2006","journal-title":"J Clin Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2004.08.186","article-title":"Gene expression profiles and molecular markers to predict recurrence of Dukes\u2019 B colon cancer.","volume":"22","author":"Wang","year":"2004","journal-title":"J Clin Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40291-019-00427-9","article-title":"The long non-coding RNA landscape of atherosclerotic plaques.","volume":"23","author":"Kraczkowska","year":"2019","journal-title":"Mol Diagn Ther"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.7754\/Clin.Lab.2019.190501","article-title":"LncRNA SNHG7 is an oncogenic biomarker interacting with MicroRNA-193b in colon carcinogenesis.","volume":"65","author":"Liu","year":"2019","journal-title":"Clin Lab"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/ijc.32747","article-title":"Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer.","volume":"146","author":"Xu","year":"2020","journal-title":"Int J Cancer"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1111\/jcmm.15070","article-title":"Long non-coding RNA POU6F2-AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR-377\/BRD4.","volume":"24","author":"Xu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/bib\/bbz131","article-title":"Landscape of cancer diagnostic biomarkers from specifically expressed genes.","volume":"21","author":"Lv","year":"2020","journal-title":"Brief Bioinform"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.molcel.2014.06.013","article-title":"Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli.","volume":"54","author":"Imamura","year":"2014","journal-title":"Mol Cell"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e00762","DOI":"10.7554\/eLife.00762","article-title":"A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics.","volume":"2","author":"Rapicavoli","year":"2013","journal-title":"Elife"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fgene.2019.00850","article-title":"lncRNA OSTN-AS1 may represent a novel immune-related prognostic marker for triple-negative breast cancer based on integrated analysis of a ceRNA network.","volume":"10","author":"Liu","year":"2019","journal-title":"Front Genet"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mc.22949","article-title":"Immune associated lncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.","volume":"58","author":"Khadirnaikar","year":"2019","journal-title":"Mol Carcinog"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1002\/jcb.28754","article-title":"Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.","volume":"120","author":"Wei","year":"2019","journal-title":"J Cell Biochem"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"9807918","DOI":"10.1155\/2020\/9807918","article-title":"Development of prognostic indicator based on autophagy-related lncRNA analysis in colon adenocarcinoma.","volume":"2020","author":"Zhou","year":"2020","journal-title":"Biomed Res Int"},{"key":"R36-20250504","first-page":"8","article-title":"Genetic variants in m6A modification genes are associated with colorectal cancer risk.","volume":"41","author":"Meng","year":"2020","journal-title":"Carcinogenesis"},{"key":"R37-20250504","first-page":"4912","article-title":"Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathicpulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway.","volume":"15","author":"Du","year":"2018","journal-title":"Oncol Lett"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cam4.2040","article-title":"Interference of the long noncoding RNA CDKN2B-AS1 upregulates miR-181a-5p\/TGF\u03b2I axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells.","volume":"8","author":"Zhu","year":"2019","journal-title":"Cancer Med"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"109029","DOI":"10.1016\/j.biopha.2019.109029","article-title":"LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a\/SIRT1 axis.","volume":"116","author":"Chu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R40-20250504","first-page":"164","article-title":"Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.","volume":"19","author":"Zhang","year":"2019","journal-title":"Bosn J Basic Med Sci"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1002\/jcp.28489","article-title":"lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity.","volume":"234","author":"Zhang","year":"2019","journal-title":"J Cell Physiol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7150\/ijbs.39582","article-title":"NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-\u03baB\/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.","volume":"16","author":"Chen","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"103968","DOI":"10.1016\/j.mvr.2019.103968","article-title":"Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-\u03baB\/IL-6 signaling pathway.","volume":"129","author":"Luo","year":"2020","journal-title":"Microvasc Res"},{"key":"R44-20250504","first-page":"37","article-title":"FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.","volume":"38","author":"Cao","year":"2019","journal-title":"BioMed Central"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbrc.2019.10.180","article-title":"Positive feedback loop SP1\/MIR17HG\/miR-130a-3p promotes osteosarcoma proliferation and cisplatin resistance.","volume":"521","author":"Meng","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-20250504","first-page":"2109","article-title":"Long non-coding RNA NKILA serves as a biomarker in the early diagnosis and prognosis of patients with colorectal cancer.","volume":"18","author":"Peng","year":"2019","journal-title":"Oncol Lett"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1002\/jcb.27902","article-title":"E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.","volume":"120","author":"Ye","year":"2019","journal-title":"J Cell Biochem"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/0008-5472.CAN-18-3880","article-title":"Long noncoding RNA MIR17HG promotes colorectal cancer progression via miR-17-5p.","volume":"79","author":"Xu","year":"2019","journal-title":"Cancer Res"},{"key":"R49-20250504","first-page":"249","article-title":"Angiogenesis in cancer and other diseases.","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nat Med"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.imbio.2009.03.004","article-title":"Activated macrophages induce metastatic behavior of colon cancer cells.","volume":"215","author":"Jedinak","year":"2010","journal-title":"Immunobiology"},{"key":"R51-20250504","first-page":"e01574861","article-title":"The preoperative peripheral blood monocyte count is associated with liver metastasis and overall survival in colorectal cancer patients.","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.06.012","article-title":"Plasmacytoid dendritic cell in immunity and cancer.","volume":"322","author":"Mitchell","year":"2018","journal-title":"J Neuroimmunol"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced non\u2013small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study.","volume":"37","author":"Garon","year":"2019","journal-title":"J Clin Oncol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-12-1630","article-title":"BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.","volume":"19","author":"Frederick","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","article-title":"Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.","volume":"38","author":"Ma","year":"2013","journal-title":"Immunity"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"112332","DOI":"10.1016\/j.ejmech.2020.112332","article-title":"Anti-tubulin agent vinorelbine inhibits metastasis of cancer cells by regulating epithelial-mesenchymal transition.","volume":"200","author":"Liu","year":"2020","journal-title":"Eur J Med Chem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:20:24Z","timestamp":1746336024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":56,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030447","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}